TipRanks
Wai Chun Bio-Technology Ltd. (HK:0660)
:0660
Hong Kong Market
0660
Wai Chun Bio-Technology Ltd.
RESEARCH TOOLSreports

Wai Chun Bio-Technology Ltd. (0660) Ratios

0 Followers

Wai Chun Bio-Technology Ltd. Ratios

HK:0660's free cash flow for Q4 2025 was HK$0.10. For the 2025 fiscal year, HK:0660's free cash flow was decreased by HK$ and operating cash flow was HK
lt;0.01. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Dec 21
Liquidity Ratios
Current Ratio
 0.67 0.39 ― 0.81 0.86
Quick Ratio
 0.40 0.18 ― 0.58 0.33
Cash Ratio
 0.03 0.02 ― 0.04 0.04
Solvency Ratio
 <0.01 >-0.01 ― >-0.01 -0.01
Operating Cash Flow Ratio
 0.12 >-0.01 ― 0.29 <0.01
Short-Term Operating Cash Flow Coverage
 0.36 -0.01 ― 0.72 <0.01
Net Current Asset Value
HK$ -139.53MHK$ -170.54MHK$ ―HK$ -100.52MHK$ -91.14M
Leverage Ratios
Debt-to-Assets Ratio
 0.61 0.44 ― 0.56 0.61
Debt-to-Equity Ratio
 -2.17 -1.05 ― -3.84 -4.01
Debt-to-Capital Ratio
 1.85 23.15 ― 1.35 1.33
Long-Term Debt-to-Capital Ratio
 5.37 0.00 ― 1.98 2.35
Financial Leverage Ratio
 -3.55 -2.36 ― -6.86 -6.63
Debt Service Coverage Ratio
 0.18 0.15 ― 0.13 0.28
Interest Coverage Ratio
 0.80 0.39 ― 0.87 1.49
Debt to Market Cap
 0.84 3.98 ― 7.80 2.26
Interest Debt Per Share
 0.82 0.63 ― 0.90 0.99
Net Debt to EBITDA
 9.15 4.95 ― 8.60 4.55
Profitability Margins
Gross Profit Margin
8.89%9.55%―6.52%8.95%
EBIT Margin
1.28%1.25%―0.00%3.10%
EBITDA Margin
2.55%4.75%―1.93%4.71%
Operating Profit Margin
1.17%1.42%―1.93%3.10%
Pretax Profit Margin
-0.18%-2.37%―-0.74%0.38%
Net Profit Margin
-1.21%-3.88%―-1.99%-2.14%
Continuous Operations Profit Margin
-0.60%-2.84%―0.00%0.00%
Net Income Per EBT
657.24%163.73%―270.85%-570.43%
EBT Per EBIT
-15.74%-166.75%―-38.26%12.10%
Return on Assets (ROA)
-3.05%-6.81%―-6.42%-5.75%
Return on Equity (ROE)
8.91%16.06%―44.09%38.07%
Return on Capital Employed (ROCE)
15.28%-8.55%―18.30%29.03%
Return on Invested Capital (ROIC)
6.44%16.46%―10.28%-4.87%
Return on Tangible Assets
-3.05%-6.81%―-6.42%-5.75%
Earnings Yield
-8.99%-61.09%―-89.57%-21.42%
Efficiency Ratios
Receivables Turnover
 11.47 11.98 ― 18.25 13.24
Payables Turnover
 5.57 4.45 ― 11.31 13.77
Inventory Turnover
 10.78 6.04 ― 19.25 6.52
Fixed Asset Turnover
 7.17 4.05 ― 6.97 6.91
Asset Turnover
 2.51 1.76 ― 3.22 2.69
Working Capital Turnover Ratio
 -4.90 -2.43 ― -28.06 -15.76
Cash Conversion Cycle
 0.17 8.92 ― 6.69 57.00
Days of Sales Outstanding
 31.83 30.46 ― 19.99 27.56
Days of Inventory Outstanding
 33.85 60.48 ― 18.96 55.94
Days of Payables Outstanding
 65.51 82.02 ― 32.27 26.50
Operating Cycle
 65.68 90.94 ― 38.96 83.51
Cash Flow Ratios
Operating Cash Flow Per Share
 0.12 >-0.01 ― 0.27 <0.01
Free Cash Flow Per Share
 -0.03 -0.16 ― 0.10 -0.10
CapEx Per Share
 0.15 0.15 ― 0.17 0.10
Free Cash Flow to Operating Cash Flow
 -0.22 26.60 ― 0.38 -42.05
Dividend Paid and CapEx Coverage Ratio
 0.82 -0.04 ― 1.61 0.02
Capital Expenditure Coverage Ratio
 0.82 -0.04 ― 1.61 0.02
Operating Cash Flow Coverage Ratio
 0.15 -0.01 ― 0.34 <0.01
Operating Cash Flow to Sales Ratio
 0.04 >-0.01 ― 0.06 <0.01
Free Cash Flow Yield
-2.83%-112.92%―100.03%-24.46%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -11.11 -1.64 ― -1.12 -4.67
Price-to-Sales (P/S) Ratio
 0.29 0.06 ― 0.02 0.10
Price-to-Book (P/B) Ratio
 -1.20 -0.26 ― -0.49 -1.78
Price-to-Free Cash Flow (P/FCF) Ratio
 -35.30 -0.89 ― 1.00 -4.09
Price-to-Operating Cash Flow Ratio
 3.60 -23.56 ― 0.38 171.92
Price-to-Earnings Growth (PEG) Ratio
 -0.07 0.02 ― -0.17 <0.01
Enterprise Value Multiple
 20.53 6.29 ― 9.75 6.67
Enterprise Value
 297.99M 112.57M ― 145.25M 210.81M
EV to EBITDA
 20.53 6.29 ― 9.75 6.67
EV to Sales
 0.52 0.30 ― 0.19 0.31
EV to Free Cash Flow
 -63.66 -4.16 ― 8.43 -12.86
EV to Operating Cash Flow
 13.97 -110.80 ― 3.20 540.54
Tangible Book Value Per Share
 -0.19 -0.36 ― 0.06 0.04
Shareholders’ Equity Per Share
 -0.36 -0.53 ― -0.21 -0.23
Tax and Other Ratios
Effective Tax Rate
 -2.39 -0.20 ― -0.77 1.37
Revenue Per Share
 3.18 2.17 ― 4.58 4.01
Net Income Per Share
 -0.04 -0.08 ― -0.09 -0.09
Tax Burden
 6.57 1.64 ― 2.71 -5.70
Interest Burden
 -0.14 -1.89 ― 0.00 0.12
Research & Development to Revenue
 <0.01 <0.01 ― 0.00 0.00
SG&A to Revenue
 0.08 0.09 ― 0.03 0.04
Stock-Based Compensation to Revenue
 <0.01 <0.01 ― 0.00 0.00
Income Quality
 -3.09 0.07 ― -2.94 -0.03
Currency in HKD